[
    {
        "molecule_name": "[3H]-prazosin",
        "protein_target_name": "α1A adrenoceptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "0.46",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "[3H]-prazosin",
        "protein_target_name": "α1A adrenoceptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "56.5",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "[3H]-prazosin",
        "protein_target_name": "α1B adrenoceptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "0,34",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "prazosin (PZS)",
        "protein_target_name": "α1A adrenoceptor",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "0.46",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "prazosin (PZS)",
        "protein_target_name": "α1A adrenoceptor",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "56.5",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "prazosin (PZS)",
        "protein_target_name": "α1B-adrenoceptor",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "0.34",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's (2-6 and 8)",
        "protein_target_name": "α1A-adrenoceptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "1.57 x 10-8",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's (2-6 and 8)",
        "protein_target_name": "α1A-adrenoceptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "2.16 x 10-9",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's (2-6, 8)",
        "protein_target_name": "α1B adrenoceptor",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "4.87 x 10-8",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's (2-6, 8)",
        "protein_target_name": "α1B adrenoceptor",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "9.07 x 10-9",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's (62-70 and 39)",
        "protein_target_name": "α1A adrenoceptor",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "61",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's (62-70 and 39)",
        "protein_target_name": "α1A adrenoceptor",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "304",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's (62-70 and 39)",
        "protein_target_name": "α1B adrenoceptor",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "54",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's (62-70 and 39)",
        "protein_target_name": "α1B adrenoceptor",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "425",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's (65-68)",
        "protein_target_name": "α2A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "0.5",
        "unit": "µM",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's (65-68)",
        "protein_target_name": "α2A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "1.5",
        "unit": "µM",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's (2-6, 8, 245)",
        "protein_target_name": "5-HT1A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "1.13 x 10-9",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's (2-6, 8, 245)",
        "protein_target_name": "5-HT1A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "2.42 x 10-10",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's (62-70, 39)",
        "protein_target_name": "5-HT1A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "5",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's (62-70, 39)",
        "protein_target_name": "5-HT1A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "147",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's (2-6 and 8)",
        "protein_target_name": "5-HT2A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "2.48 x 10-7",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's (2-6 and 8)",
        "protein_target_name": "5-HT2A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "4.74 x 10-8",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's (62-70, 39)",
        "protein_target_name": "5-HT2A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "1.47",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's (62-70, 39)",
        "protein_target_name": "5-HT2A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "40.4",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's",
        "protein_target_name": "α2A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "0.16",
        "unit": "µM",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's",
        "protein_target_name": "α2A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "0.93",
        "unit": "µM",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's",
        "protein_target_name": "muscarinic receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "10.8",
        "unit": "µM",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's",
        "protein_target_name": "muscarinic receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "56.7",
        "unit": "µM",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's",
        "protein_target_name": "D2 dopaminergic receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "0.004",
        "unit": "µM",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's",
        "protein_target_name": "D2 dopaminergic receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "0.186",
        "unit": "µM",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's",
        "protein_target_name": "human prostate cells",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "proliferation percentage",
        "value": "76",
        "unit": "%",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    },
    {
        "molecule_name": "LDT's",
        "protein_target_name": "human prostate cells",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "proliferation percentage",
        "value": "138",
        "unit": "%",
        "raw_mentions": "Here are the extracted sentences with concrete data points that match the specified criteria:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nThe values of Kd and Bmax obtained in previous laboratory experiments were 1.77 ± 0.07 nM and 348 ± 51 fmol / mg protein, respectively.\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\nThe Kd value was used to calculate Ki of LDT's using Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\nKi values were calculated using the Cheng-Prusoff equation, and the obtained Ki values are summarized in the following Tables 3 to 5 below.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values ranging from 1.57 x 10-8 to 2.16 x 10-9 M.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values ranging from 4.87 x 10-8 to 9.07 x 10-9 M.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values ranging from 61 to 304 nM for α1A and 54 to 425 nM for α1B.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values ranging from 0.5 to 1.5 µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values ranging from 1.13 x 10-9 to 2.42 x 10-10 M.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values ranging from 5 to 147 nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki ratios ranging from 0.34 to 1.21.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values ranging from 2.48 x 10-7 to 4.74 x 10-8 M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values ranging from 1.47 to 40.4 nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values ranging from 0.16 to 0.93 µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki ratios ranging from 1.1 to 34.4.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values ranging from 10.8 to 56.7 µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values ranging from 0.004 to 0.186 µM.\nTable 16. LDT's effect on the in vitro proliferation of human prostate cells, with proliferation percentages ranging from 76 to 138%."
    }
]